Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metformin

D. Šimčíková, D. Gardáš, K. Hložková, M. Hruda, P. Žáček, L. Rob, P. Heneberg

. 2021 ; 9 (1) : 41. [pub] 20211211

Language English Country Great Britain

Document type Journal Article

Grant support
324421 Grantová Agentura, Univerzita Karlova
1428218 Grantová Agentura, Univerzita Karlova
260531/SVV/2020 Univerzita Karlova v Praze

BACKGROUND: Hexokinases (HKs) are well-studied enzymes catalyzing the first step of glycolysis. However, non-canonical regulatory roles of HKs are still incompletely understood. Here, we hypothesized that HKs comprise one of the missing links between high-dose metformin and the inhibition of the respiratory chain in cancer. METHODS: We tested the isoenzyme-specific regulatory roles of HKs in ovarian cancer cells by examining the effects of the deletions of HK1 and HK2 in TOV-112D ovarian adenocarcinoma cells. We reverted these effects by re-introducing wild-type HK1 and HK2, and we compared the HK1 revertant with the knock-in of catalytically dead HK1 p.D656A. We subjected these cells to a battery of metabolic and proliferation assays and targeted GC×GC-MS metabolomics. RESULTS: We found that the HK1 depletion (but not the HK2 depletion) sensitized ovarian cancer cells to high-dose metformin during glucose starvation. We confirmed that this newly uncovered role of HK1 is glycolysis-independent by the introduction of the catalytically dead HK1. The expression of catalytically dead HK1 stimulated similar changes in levels of TCA intermediates, aspartate and cysteine, and in glutamate as were induced by the HK2 deletion. In contrast, HK1 deletion increased the levels of branched amino acids; this effect was completely eliminated by the expression of catalytically dead HK1. Furthermore, HK1 revertants but not HK2 revertants caused a strong increase of NADPH/NADP ratios independently on the presence of glucose or metformin. The HK1 deletion (but not HK2 deletion) suppressed the growth of xenotransplanted ovarian cancer cells and nearly abolished the tumor growth when the mice were fed the glucose-free diet. CONCLUSIONS: We provided the evidence that HK1 is involved in the so far unknown glycolysis-independent HK1-metformin axis and influences metabolism even in glucose-free conditions.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22001060
003      
CZ-PrNML
005      
20220112153452.0
007      
ta
008      
220107s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s40170-021-00277-2 $2 doi
035    __
$a (PubMed)34895333
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Šimčíková, Daniela $u Third Faculty of Medicine, Charles University, Ruská 87, CZ-100 00, Prague, Czech Republic
245    10
$a Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metformin / $c D. Šimčíková, D. Gardáš, K. Hložková, M. Hruda, P. Žáček, L. Rob, P. Heneberg
520    9_
$a BACKGROUND: Hexokinases (HKs) are well-studied enzymes catalyzing the first step of glycolysis. However, non-canonical regulatory roles of HKs are still incompletely understood. Here, we hypothesized that HKs comprise one of the missing links between high-dose metformin and the inhibition of the respiratory chain in cancer. METHODS: We tested the isoenzyme-specific regulatory roles of HKs in ovarian cancer cells by examining the effects of the deletions of HK1 and HK2 in TOV-112D ovarian adenocarcinoma cells. We reverted these effects by re-introducing wild-type HK1 and HK2, and we compared the HK1 revertant with the knock-in of catalytically dead HK1 p.D656A. We subjected these cells to a battery of metabolic and proliferation assays and targeted GC×GC-MS metabolomics. RESULTS: We found that the HK1 depletion (but not the HK2 depletion) sensitized ovarian cancer cells to high-dose metformin during glucose starvation. We confirmed that this newly uncovered role of HK1 is glycolysis-independent by the introduction of the catalytically dead HK1. The expression of catalytically dead HK1 stimulated similar changes in levels of TCA intermediates, aspartate and cysteine, and in glutamate as were induced by the HK2 deletion. In contrast, HK1 deletion increased the levels of branched amino acids; this effect was completely eliminated by the expression of catalytically dead HK1. Furthermore, HK1 revertants but not HK2 revertants caused a strong increase of NADPH/NADP ratios independently on the presence of glucose or metformin. The HK1 deletion (but not HK2 deletion) suppressed the growth of xenotransplanted ovarian cancer cells and nearly abolished the tumor growth when the mice were fed the glucose-free diet. CONCLUSIONS: We provided the evidence that HK1 is involved in the so far unknown glycolysis-independent HK1-metformin axis and influences metabolism even in glucose-free conditions.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gardáš, Dominik $u Third Faculty of Medicine, Charles University, Ruská 87, CZ-100 00, Prague, Czech Republic
700    1_
$a Hložková, Kateřina $u CLIP - Childhood Leukaemia Investigation Prague, Prague, Czech Republic $u Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hruda, Martin $u Third Faculty of Medicine, Charles University, Ruská 87, CZ-100 00, Prague, Czech Republic $u University Hospital Kralovské Vinohrady, Prague, Czech Republic
700    1_
$a Žáček, Petr $u Faculty of Science, BIOCEV, Charles University, Vestec, Czech Republic
700    1_
$a Rob, Lukáš $u Third Faculty of Medicine, Charles University, Ruská 87, CZ-100 00, Prague, Czech Republic $u University Hospital Kralovské Vinohrady, Prague, Czech Republic
700    1_
$a Heneberg, Petr $u Third Faculty of Medicine, Charles University, Ruská 87, CZ-100 00, Prague, Czech Republic. petr.heneberg@lf3.cuni.cz
773    0_
$w MED00208612 $t Cancer & metabolism $x 2049-3002 $g Roč. 9, č. 1 (2021), s. 41
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34895333 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220107 $b ABA008
991    __
$a 20220112153448 $b ABA008
999    __
$a ind $b bmc $g 1745345 $s 1152207
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 9 $c 1 $d 41 $e 20211211 $i 2049-3002 $m Cancer & metabolism $n Cancer Metab $x MED00208612
GRA    __
$a 324421 $p Grantová Agentura, Univerzita Karlova
GRA    __
$a 1428218 $p Grantová Agentura, Univerzita Karlova
GRA    __
$a 260531/SVV/2020 $p Univerzita Karlova v Praze
LZP    __
$a Pubmed-20220107

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...